Spectral Imaging Deep Tissue Autofluorescence
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current deep tissue imaging techniques face challenges in accurately detecting weak light signals from deep structures due to interference from autofluorescence, which sets a high detection threshold and can lead to false positive readings and unreliable results.
Innovation Solution
The use of spectral discrimination techniques to decompose spectrally resolved information into contributions from different components, allowing for the construction of images that preferentially show selected components by estimating pure spectra from mixed signals using algorithms that require minimal user input, and the application of spectral filtering methods to reduce autofluorescence interference.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If spectral filtering methods are used to reduce autofluorescence interference, then detection sensitivity of target compounds is enhanced, but device complexity increases
Solution Approach 1:
The patent segments the detection process into multiple spectral channels, each optimized for detecting specific target compounds while rejecting autofluorescence. The imaging system captures images at multiple wavelengths and uses spectral unmixing algorithms to separate target signal from background autofluorescence, thereby enhancing detection sensitivity without requiring complex hardware modifications
Solution Approach 2:
The patent introduces spectral filtering methods and algorithms as intermediaries between the light source and detector. By using spectral unmixing algorithms that analyze the spectral signature of different components, the system can distinguish target compounds from autofluorescence without direct physical separation, reducing the need for complex physical filtering hardware
2Measurement precision
If spectral discrimination techniques are applied to decompose spectrally resolved information, then measurement precision of target compounds improves, but difficulty of detecting and measuring increases
Solution Approach 1:
The patent performs preliminary spectral characterization of both target compounds and autofluorescence backgrounds before actual detection. By预先 establishing spectral libraries and reference profiles, the system simplifies subsequent detection tasks, as the complex spectral decomposition relies on comparing against pre-characterized signatures rather than solving the full decomposition problem in real-time
Solution Approach 2:
The patent implements iterative spectral unmixing algorithms that use feedback from initial decomposition results to refine spectral estimates. The system repeatedly adjusts the decomposition parameters based on how well the reconstructed spectra match the observed data, thereby reducing the difficulty of measuring complex spectral mixtures through progressive refinement
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the detection sensitivity of target compounds by isolating their signals from autofluorescence, enabling more accurate and reliable imaging of deep tissue structures with reduced background interference, even in low light conditions.
Implementation Method 1
fluorescent agents which are associated with a specific target in the specimen are imaged by exciting them with illumination light, causing them to fluoresce
Implementation Method 2
the fluorescent emission is separated from the illumination light, which has a different wavelength, by barrier filters
Data Source
AI summary
The invention features a method including: (i) providing spectrally resolved information about light coming from different spatial locations in a sample comprising deep tissue in response to an illumination of the sample, wherein the light includes contributions from different components in the sample; (ii) decomposing the spectrally resolved information for each of at least some of the different spatial locations into contributions from spectral estimates associated with at least some of the components in the sample; and (iii) constructing a deep tissue image of the sample based on the decomposition to preferentially show a selected one of the components.